CLNN
Clene Inc.NASDAQHealthcare$5.12+4.70%ClosedMarket Cap: $51.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-3.23
P/S
288.00
EV/EBITDA
-3.43
DCF Value
$-1.81
FCF Yield
-32.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
78.5%
Operating Margin
-11541.5%
Net Margin
-13086.5%
ROE
240.8%
ROA
-144.4%
ROIC
-188.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $77.0K | 70.1% | $-7.5M | $-9.2M | $-0.93 | — |
| FY 2025 | $200.0K | 78.5% | $-23.1M | $-26.2M | $-2.65 | — |
| Q3 2025 | $15.0K | 100.0% | $-5.6M | $-8.8M | $-0.85 | — |
| Q2 2025 | $27.0K | 100.0% | $-5.9M | $-7.4M | $-0.78 | — |
| Q1 2025 | $81.0K | 75.3% | $-4.1M | $-751.0K | $-0.09 | — |
| Q4 2024 | $91.0K | 80.2% | $-8.7M | $-13.5M | $-1.95 | — |
| FY 2024 | $342.0K | 79.5% | $-33.1M | $-39.4M | $-5.67 | — |
| Q3 2024 | $87.0K | 79.3% | $-7.8M | $-8.0M | $-1.22 | — |
| Q2 2024 | $91.0K | 80.2% | $-7.4M | $-6.8M | $-1.06 | — |
| Q1 2024 | $73.0K | 78.1% | $-9.2M | $-11.1M | $-1.73 | — |
| Q4 2023 | $170.0K | -170.6% | $-9.9M | $-10.2M | $-1.58 | — |
| FY 2023 | $654.0K | 81.5% | $-40.5M | $-49.5M | $-9.43 | — |